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  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
  
ﻣﻦ اﻻﻣﺮاض اﻟﻬﺎﻣﺔ ﻓﻰ ( اﺑﻮ ﻧﻴﻨﻰ)ﻣﺮض اﻻﻟﺘﻬﺎب اﻟﺮﺋﻮى اﻟﺒﻠﻮرى اﻟﺴﺎرى ﻓﻰ اﻟﻤﺎﻋﺰ   
اﻟﺴﻮدان ﺣﻴﺚ ﻳﺆدى اﻟﻰ ﻧﻔﻮق اﻋﺪاد آﺒﻴﺮة  ﻣﻦ اﻟﺤﻴﻮاﻧﺎت ﻟﺬﻟﻚ اهﺘﻤﺖ اﻟﺪراﺳﺔ ﺑﻬﺬا اﻟﻤﺮض ﻟﻤﻌﺮﻓﺔ 
ﻪ وﺳﺒﻞ اﻟﺴﻴﻄﺮة ﻣﺪى اﻧﺘﺸﺎرﻩ ﻓﻲ اﻟﺴﻮدان وﺗﻮﻓﻴﺮ ﺑﻌﺾ اﻟﻌﺘﺮات اﻟﻤﺴﺒﺒﺔ ﻟﻠﻤﺴﺎﻋﺪة ﻓﻲ دراﺳﺔ وﺑﺎﺋﻴﺘ
 ﻋﻴﻨﺔ ﻣﺼﻠﻴﺔ ﻣﻦ اﻟﺴﻠﺨﺎﻧﺎت و اﻟﺤﻘﻞ ﻣﻦ ﻣﻨﺎﻃﻖ 315 ﻣﺼﺎﺑﺔ  و  ﻋﻴﻨﺔ رﺋﺔ613ﺗﻢ ﺟﻤﻊ ﻋﺪد . ﻋﻠﻴﻪ
ﻣﺨﺘﻠﻔﺔ ﻣﻦ اﻟﺴﻮدان  ، ﺗﺘﻤﺜﻞ ﻓﻰ وﻻﻳﺔ ﺟﻨﻮب دارﻓﻮر ، وﻻﻳﺔ اﻟﺨﺮﻃﻮم ، وﻻﻳﺔ آﺴﻼ و آﺬﻟﻚ وﻻﻳﺔ 
اﻟﺴﺎﺋﻠﺔ و (  ﻴﻼ و هﻴﻔﻠﻴﻚاﻟﺒﺮوﺳ)ﺗﻢ ﺗﺰرﻳﻊ اﻟﻌﻴﻨﺎت ﻓﻲ  ﻧﻮﻋﻴﻦ ﻣﻦ اوﺳﺎط اﻻﺳﺘﺰراع . اﻟﺒﺤﺮ اﻻﺣﻤﺮ
 ﻋﻴﻨﺔ رﺋﺔ ﻣﻦ 052 ﻋﺘﺮات ﻣﻨﻬﺎ ﻣﻦ ﻋﺪد 5.  اﻟﺼﻠﺒﺔ و ﺗﻢ ﻋﺰل ﻋﺪد ﺳﺒﻊ ﻋﺘﺮات ﻣﻦ اﻟﻤﺎﻳﻜﻮﺑﻼزﻣﺎ
 ﻋﻴﻨﺔ رﺋﺔ ﻣﻦ وﻻﻳﺔ اﻟﺨﺮﻃـــﻮم و آﺬﻟﻚ ﻋﺰل ﻋﺘﺮة 52ﺟﻨﻮب دارﻓﻮر و ﻋﺰل ﻋﺘﺮة واﺣﺪة ﻣﻦ ﻋﺪد 
ﺑﻴﻮ ) ﺧﺘﺒــــــﺎرات اﻟﻼزﻣـــﺔ و ﺑﻌﺪ اﺟﺮاء ﺟﻤﻴـﻊ اﻻ.   ﻋﻴﻨﺔ رﺋﺔ ﻣﻦ وﻻﻳﺔ آﺴﻼ42واﺣﺪة ﻣﻦ ﻋﺪد 
  .ﺗﻢ اﻟﺘﺄآﺪ ﻣﻦ ﻋﺰل ﻣﺴﺒﺐ هﺬا اﻟﻤﺮض( آﻴﻤﻴﺎﺋﻴـــــــﺔ و ﺳﻴﺮوﻟﻮﺟﻴﺔ و ﺟﺰﻳﺌﻴﺔ
ﻟﻠﻌﻴﻨﺎت اﻟﻤﺼﻠﻴﺔ  وﺟﺪ أن ﻧﺴﺒﺔ اﻟﻌﻴﻨﺎت اﻟﻤﻮﺟﺒﺔ ( TFC)و ﺑﺎﺳﺘﺨﺪام اﺧﺘﺒﺎر ﺗﺜﺒﻴﺖ اﻟﻤﺘﻤﻤﺔ   
ﻳﺔ آﺴﻼ و  ﻓﻲ وﻻ%  5.83ﻓﻲ وﻻﻳﺔ اﻟﺨﺮﻃﻮم و % 03ﻓﻲ وﻻﻳﺔ ﺟﻨﻮب دارﻓﻮر و   %5.33آﺎﻧﺖ 
آﻤﺎ وﺟﺪ أن أﻋﻠﻰ ﻣﻘﺪار ﻟﻸﺟﺴﺎم اﻟﻤﻀﺎدة ﻗﺪ ﺗﻢ رﺻﺪﻩ ﻓﻲ ﻋﻴﻨﺎت . ﻓﻲ وﻻﻳﺔ اﻟﺒﺤﺮ اﻷﺣﻤﺮ% 63
 .دارﻓﻮر
ﺧﻠﺼﺖ اﻟﺪراﺳﺔ إﻟﻰ أن اﻟﻤﺮض ﻣﻨﺘﺸﺮ ﻓﻲ اﻟﻮﻻﻳﺎت اﻟﺘﻲ ﺷﻤﻠﺘﻬﺎ اﻟﺪراﺳﺔ و ﻻﺑﺪ ﻣﻦ      
  .إﺟﺮاء ﻣﺰﻳﺪ ﻣﻦ اﻷﺑﺤﺎث ﻓﻲ ﺑﻘﻴﺔ اﻟﻮﻻﻳﺎت
 
 
 
 
 
 
 
 English Abstract 
  
             The main goal of this research was to study the distribution of CCPP 
in the Sudan. A total number of 316 lung samples and 513 serum samples 
were collected from Southern Darfuor, Khartoum, Kassala and Red Sea 
States. Lung tissues were cultured on two different media (Brucella and 
Hayflick´s) for isolation of mycoplasma. 
  Seven isolates of Mycoplasma were recovered; 5 isolates from 
Southern Darfuor, one isolate from Khartoum state and one isolate from 
Kassala state. Isolates were identified as mycoplasma capricolum subsp 
capripneumoniae (Mccp) using conventional serological and molecular 
techniques. 
       Serum samples were investigated for Abs against Mccp using CFT. 
33.5% of samples collected from Southern Darfuor state, 30% of samples 
from Khartoum state, 38.5% of samples from Kassala state and 36% of 
samples from Red Sea state were found to be positive. Higher antibody titers 
were detected in sera collected from Southern Darfuor state. 
It was concluded from the study that CCPP is present in the 
investigated states and further work should be done to investigate other 
country States 
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                                          INTRODUCTION 
 
 Contagious caprine pleuropneumonia (CCPP) is one of the most 
serious diseases of goat in Africa and Asia. The disease is devastating 
causing high morbidity and mortality rates and represents a major cause of 
loss in goat rearing in nearly forty countries distributed in these continents 
(Bölske et al., 1996). Accordingly, it is included in B list of communicable 
animal diseases of the Office International des Epizooties (OIE) due to its 
economic impact. 
In the Sudan the disease is widely distributed with higher incidences 
in winter and rainy months. It represents a real threat to goat population in 
the country which is estimated to be about 39.952.000 heads (Federal 
Ministry of Animal Res. and Fisheries Report, 2001) although it is difficult 
to make a precise estimation of the economic impact of CCPP; it is obvious 
that losses due to the disease are considerable. Thousands of animals die 
annually in different states of Sudan due to CCPP outbreaks. In addition, 
restrictions in exportation of goats due to CCPP affect the contribution of 
livestock in the national income. It is estimated that 30% of the total hard 
currency income of the Sudan results from the export of cattle, sheep, goats, 
camels and their meat and hides.  
             Based on veterinary reports, the disease spreads in most country 
states. However, a precise distribution, based on scientific data, is not 
available. The main reasons behind that appear from the difficulty 
encountered in the isolation of the causative agent in the laboratory. 
Mycoplasma capricolum subsp. capripneumoniae (Mccp) was isolated only 
once in the Sudan from a diseased goat showing typical symptoms of CCPP 
in Khartoum state (Harbi et al., 1981).  
At present, detection of the disease is based mainly on clinical signs 
and post-mortem findings. Both tools diagnose the disease tentatively. 
However, confirmatory diagnosis is mainly by the isolation and 
identification of the causative agent, serological test and poly mrease chain 
reaction (Thiaucourt and Bölske, 1996). 
The present research work was designed to study the disease in 
different states in which it was reported to be endemic. The following 
objectives were achieved: 
• Detection of the disease in Southern Darfur, Khartoum, 
Kassala and Red Sea states by isolation of the causative agent. 
•  Identification of the isolates using conventional methods and 
PCR-REA technique. 
• Serological screening of randomly collected goat sera from the 
selected states for antibodies against Mccp using complement 
fixation test. 
 
 
 
CHAPTER ONE 
 
1. Literature Review 
 
1.1. History: 
 Contagious caprine pleuropneumonia (CCPP) is a serious 
mycoplasma disease of goats. The disease was first reported in Algeria by 
Thomas (1873). In 1881-1889 it was described to be contagious following 
outbreaks in the Eastern Province of South Africa (Hutcheon, 1881). 
Hutcheon related these outbreaks to the importation of Angora rams from 
Turkey the year before. He characterized the disease and referred to as the 
classical contagious caprine pleuropneumonia. He explained that the 
classical CCPP differs from other caprine pleuropneumonia in that the 
classical form is contagious, affects only goats and lesions are restricted to 
the thoracic cavity. 
Isolation of the causative agent was achieved for the first time during 
outbreaks of CCPP in Kenya in the 1970s. It was first designated as 
Mycoplasma species strain F38 (MacOwan and Minette, 1976). The second 
isolation report was recorded in the Sudan in 1981 (Harbi et al., 
1981).Thereafter only thirteen countries declared the presence of the disease 
by isolation of the causative agent.  
At present nearly forty countries declared the presence of the disease 
depending on serological and molecular biological techniques (Thiaucourt 
and Bölske, 1996).  M. strain F38 was proved to cause a disease similar to 
that described by Hutcheon (1881) and the disease was reproduced 
experimentally by some authors. In the 1990s,  
Mycoplasma strain F38 was designated Mycoplasma capricolum 
subsp. capripneumoniae (Mccp) (Leach, Erno and MacOwan, 1993). It is 
now accepted that Mccp is the causative agent of CCPP (Jones, 1992; 
Damassa et al., 1992).   
In the Sudan, the disease is known as Abu Nini. The earliest reference 
to this disease was in the beginning of the last century in the Annual Reports 
of the Sudan Veterinary Department (Anon, 1902). Goats with 
pleuropneumonia were first reported in Kassala and later in Upper Nile, 
Blue Nile, Khartoum, Kordofan and Bahar El gazal Provinces. Even as late 
as 1958 attempts to isolate the causal organism had been largely 
unsuccessful (Anon, 1958). Karib (1958) succeeded in setting up lung 
lesions by spraying diluted lung fluid from an infected animal into the 
nostrils of three goats. Abdulla and Lindly (1967) achieved the primary 
isolation of a mycoplasma from a goat with pleuropneumonia. However, the 
maintenance of this isolate was always unsuccessful. They reported also 
attempts to cross infect cattle, goats and sheep with caprine and bovine 
strains of Mycoplasma of local origin but it was considered necessary to 
repeat and confirm their observations. The first successful isolation trial was 
carried out by Harbi et al. (1981) who recovered Mccp isolate from a goat 
with acute pleuropneumonia in Khartoum state. They designated that isolate 
as strain SPG1. 
1.2. Aetiology: 
 CCPP is caused by Mycoplasma capricolum subsp. capripneumoniae 
(Mccp). The causative agent belongs to the so called Mycoplasma mycoides 
cluster, which is a group of mycoplasma of particular importance in 
veterinary medicine (Table 1). Members of this   
cluster are biochemically and antigenically closely related rendering diseases 
caused by them very difficult to diagnose. Goat pleuropneumonia is caused 
by three different mycoplasmes; Mycoplasma mycoides subsp. capri, 
Mycoplasma mycoides subsp. Mycoides (LC) and Mycoplasma capricolum 
subsp. capripneumoniae. However, only Mccp causes the classical 
contagious caprine pleuropneumonia as explained earlier (Table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table (1): The Mycoplasma mycoides cluster (Bölske, 1995). 
 
Mycoplasma 
Type strain 
Principal animal 
host 
Diseases 
Other animal 
host 
M. Mycoides 
subsp. mycoides 
(Sc type) 
PG1 Cattle CBPP 
Buffaloes, 
goats, sheep 
M. Mycoides 
subsp. capri 
PG3 Goats 
Pleuropneumonia, 
arthritis 
- 
M. Mycoides 
subsp. mycoides. 
(Lc type) 
Y-goat Goats Pleuropneumonia Sheep, Cattle 
M. capricolum 
subsp. 
capripneumoniae 
F38 Goats CCPP Sheep 
M. capricolum 
subsp. capricolum 
California 
kid 
Goats Arthritis, Mastitis Sheep, cattle 
Mycoplasma sp. 
Bovine group 7 
(Leach) 
PG50 Cattle Arthritis Goats, sheep 
 
 
 
 
 
 
 
1.2.1. Mycoplasma capricolum subsp. capripneumoniae strains: 
 Strain F38 is the type strain of Mccp. Different strains were isolated 
from different countries in Africa and Asia (Table 2) (Pettersson et al., 
1998). Molecular characterization of these strains revealed valuable results 
that classify them into many groups and help in understanding the 
epidemiology of the disease. The members of the M. mycoides cluster have 
two rRNA operons, designated rrnA and rrnB (Christiansen and Ernø, 
1990). The sequences of the 16S rRNA genes of both rRNA operons from 20 
strains of Mccp of different geographical origins in Africa and Asia were 
determined (Pettersson et al., 1998). A phylogenetic tree was constructed by 
comparative analysis of polymorphism in the genes and the tree revealed 
two distinct lines of descent. Representatives of line I were found only in 
Africa, whereas representatives of line II were found in both Africa and 
Asia. Representatives of line I was isolated in Niger, Chad, Kenya and 
Uganda. Strains of line II were found in countries bordering maritime routes 
(Mediterranean Sea: Turkey, Tunisia; Indian Ocean: Kenya, Oman; Red Sea: 
Ethiopia, Sudan). The occurrence of the same type in neighboring countries 
was observed. Similar strains were detected in Kenya and Uganda; and in 
Kenya and Sudan. The finding was explained by trade and other movement 
of animals across these borders.  
  
 
 
 
 
 
 
  
 
 
 
 
 
 
Table (2):  Different Mccp strains isolated in different countries. 
 
 
 
 
 
 
 
 
 
 
Strain Origin Year of 
isolation 
F38 Kenya  1976 
G1943 Kenya 1980 
SGP1 Sudan 1981 
G4/83 Kenya 1983 
Gabes strain Tunisia 1984 
4/2 LC  Oman  1988 
7/1a Turkey 1988 
19/2 Oman 1988 
Strain 95043 Niger 1995 
1.3. Symptoms and pathology 
1.3.1. Clinical sings: 
 The primary symptoms are cough and the animals tend to lie down or 
lag behind the flock. The incubation period is usually between 6 and 10 days 
but some times much longer. Affected animals continue to graze for some 
time but eventually breathing becomes labored with painful grunting and the 
temperature rises to over 40oC. In the terminal stages, the animal stands with 
open mouth and dribbling frothy saliva. The tongue is protruding and the 
goat bleats distressingly (McMartin et al., 1980).  
 Respiration was mainly abdominal with groaning and twitching of the 
nostrils. Coughing is frequent during inspiration (Rurangirwa et al., 1981). 
Percussion of chest wall reveals dull areas on one or both sides (Babiker, 
1971). On auscultation harsh respiratory sounds were heard over the 
bronchial area (OJO, 1976). 
 Nasal discharge appears first watery, later turned mucoidly and 
purulent (Babiker, 1971; Abdulla et al., 1980). 
The disease is manifested in three forms; per-acute, acute and chronic. 
The course of per-acute form is 3-5 days and some times 12-24 hours from 
the onset of the disease. The acute form lasts from 3 to 8 days (Lindley, 
1967), but it may turn to be chronic (Longley, 1951). 
1.3.2. Post-mortem Findings:  
 On post-mortem there is extensive fibrinous pleuropneumonia. The 
lung lesions show enclosed areas of gray to white necrotic tissue varying in 
size from 1-2 mm to several centimeters. Lesions are bilateral with the right 
lung being more intensively involved. There are extensive deposits of 
fibrinous exudates on the visceral and parietal pleura. The lungs often adhere 
to the thoracic wall and the diaphragm and on section they are friable 
(Rurangirwa et al., 1981; MacOwan, 1976). In acute cases the pleura is 
covered with thick, yellow, fibrinous material and the pleural cavity contains 
excess of straw-coloured fluid with fibrin floccules (Kaliner and MacOwan, 
1976; Wesonga et al., 1993). 
1.3.3. Histopathology: 
 Histopatholgical examination of the lung tissues reveals acute 
serofibrinous to chronic fibrinonecrotic pleuropnumonia. There is infiltration 
of serofibrinous fluid and inflammatory cells, mainly neutrophils, in the 
alveoli, bronchioles, interstitial septae and subpleural connective tissue. 
Intralobular oedema is more prominent. Peribronchial and perivascular 
lymphoid hyperplasia are seen. 
1.4. Epidemiology: 
1.4.1. Affected animals: 
       Regarless of sex and age, CCPP was reported to affect only goats 
(Thiaucourt and Bölske, 1996). In susceptible flocks morbidity may reach 
100% while mortality up to 70%. 
        At first, it was reported that Mycoplasma capricolum subsp. 
capripneumoniae does not cause disease in sheep, neither spontaneously nor 
experimentally (McMartin et al., 1980). Later, some reports described the 
isolation of Mccp from healthy sheep in Kenya that were in contact with 
goat herds affected by CCPP (litamoi et al., 1990). However, in Uganda 
Mccp was isolated from sick sheep mixed with goats suffering from the 
disease (Bölske et al., 1995).  
The isolation of Mccp from cattle with mastitis has also been reported 
(kumar and Garg, 1991). In Sudan cattle were reported to be resistant 
naturally or experimentally to Mccp (Lindley, 1967; Abdulla and Lindley, 
1967).  
Mycoplasmas in general are described to be host specific. 
Accordingly, all previous reports, which entail the detection of Mccp in 
animal species other than goats, should be interpreted with caution (Paling et 
al., 1978; Hung et al., 1991). 
1.4.2. Distribution of CCPP in the world: 
 Table 3 shows countries in which CCPP was detected (Nicholas, 
2002). Only thirteen countries confirmed the presence of the disease by the 
isolation of the causative agent, principally because Mccp is difficult to 
culture in the laboratory (Thiaucourt and Bölske, 1996). These countries 
include Kenya (MacOwan et al., 1976), Sudan (Harbi et al., 1981), Tunissia 
(Perreau et al., 1984), Chad (Lefevere et al., 1987), Ethiopia (Thiaucourt et 
al., 1992), Uganda (Bölske et al., 1995 ), Tanzania (Kusiluka et al., 2000) 
and Eritrea (Nicolas, 2002) in Africa.   
 In Asia and the Mediterranean, Mccp was isolated in Yemen 
(Rurangirwa et al., 1987), Oman (Jones and Wood, 1988) and Turkey 
(Turkarslan et al., 1990).  
 CCPP were reported in other countries by other diagnostic methods 
including clinical signs. In Mali, the presence of CCPP was reported based 
on serological evidence (Rurangirwa et al., 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (3): Distribution of CCPP in Africa and Asia: 
 
Clinical disease 
reported or suspected 
Confirmed by isolation 
of mycoplasma 
 
Algeria, Burkina Faso, 
Benin, Cameroon, Central 
African Republic, Djibouti, 
Egypt, Libya, Mali, Nigeria, 
Somali, Zaire 
 
Chad, Eritrea, Ethiopia, 
Kenya, Niger, Sudan, 
Tunisia, Uganda 
 
Africa 
Afghanistan, Bangladesh, 
India, Iran, Iraq, Israel, 
Jordan, Kuwait, Lebanon, 
Pakistan, Saudi Arabia, 
Syria 
Nepal, Oman, United Arab 
Emirates, Turkey, Yemen 
Asia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.4.3. Transmission of the disease: 
            The environment plays an important role in the appearance, 
evolution and severity of CCPP. Due to the high sensitivity of mycoplasmas 
to the external environment, close contact is essential between infected and 
naive animals for transmission. Overcrowding and confinement favor close 
contact and circulation of Mccp. Stress factors due to malnutrition and 
movement over long distances can predispose the animal to disease. 
              In Africa where extensive and traditional husbandry is practiced, 
pathogens spread when animals meet at watering points and grazing areas. 
Mccp may persist in chronic and latent carriers. Such animals may recover 
from infection without becoming bacteriologically sterile, and are 
considered to be responsible for the perpetuation of the disease in a herd 
(Thiaucourt and Bölske, 1996; Wesonga et al., 1998). This aspect of the 
epidemiology was described as early as 1881 by Hutcheon in the case of 
CCPP in South Africa (McMartin et al., 1980). 
             Experimental transmission of the disease was described by some 
authors. The disease was transmitted intranasally (Chu et al., 1949 and 
Karib, 1958), intratracheal endobronchially (Abdulla and Lindely, 1967), 
and by contact infection (Lindley, 1967; MacOwan and Minette, 1976; 
Harbi et al., 1983). 
1.5. Diagnosis: 
Tentative diagnosis is based on clinical signs, PM findings and 
demonstration of Mccp in pleural fluid by dark-field microscopy. 
Confirmatory diagnosis is based mainly on isolation and identification of the 
causative agent. 
 
1.5.1. Isolation of Mccp: 
1.5.1.1. Samples: 
 Pleural fluid represents the suitable sample from a live diseased goat 
(Abdulla and lindelly 1967 and Abdalla et al., 1980). The causative agent 
can also be isolated from nasal swabs (Litamoi et al., 1990) with difficulty 
as these samples are highly contaminated with normal flora. Pneumonic lung 
tissues, lymph nodes and pleural fluid represent the best samples from dead 
animals. Samples should be transported to the laboratory as quick as 
possible and cultured immediately in suitable media. Otherwise they should 
be stored frozen at -20°C or lyophilized (Nicholas, 2002).  
 Among the members of the M. mycoides cluster, Mccp is more 
fastidious and requires media of special composition and high quality 
(Bölske, 1995). Generally media should be supported with high percentage 
of horse serum (20%). Addition of sodium pyruvate to medium enhances the 
growth both for primary isolation and antigen production (Mohan and 
Wadher, 1990). Different media were used for the cultivation of Mccp. The 
first successful isolation trial was achieved in Viande foie goat medium 
(MacOwan and Minette 1976). Other media include meat-liver medium (Al-
Aubaidi and Fabricant, 1972), Modified Hayflick´s medium (Thiaucourt and 
Bölske, 1996), WJ and Newings tryptose media (Jones, 1988). A 
commercial medium called Mycoplasma Experience medium is also 
available from Mycoplasma Experience, Reigate, Surrey, UK (Nicolas, 
2002). 
  
 
 
 
1.5.1.2. Processing and cultivation of samples: 
 Swabs are suspended in 2-3 ml of culture medium. Tissue samples are 
best minced using scissors, and then shaken vigorously, or pulverized in 
medium using 1 g of tissue to 9 ml of medium. Tissues should not be 
ground. The suspension is usually prepared with a mycoplasma medium. 
Pleural fluid, or a tissue suspension or swab, is serially diluted through at 
least three tenfold steps (to a nominal 10-4) in the selected mycoplasma 
medium. Dilutions should also be cultured onto solid medium (OIE, 
1991).Broth Cultures are incubated at 37oC while solid media incubated at 
the same temperature under 5% CO2 in moist chamber (candle jar).  
Broth cultures are examined daily for evidence of growth, namely colour 
change and appearance of follicular material.  Gross turbidity is an 
indicative of bacterial contamination; culture showing this should be passed 
through membrane filters of 0.45 µm before subculture. On primary 
isolation, broth media which have shown no indication of growth by 7 days 
should be subcultured blindly. Strain F38 in early passage often does not 
produce marked change in the pH. Broth cultures of each sample, including 
one blind passage subculture should be retained for a minimum of three 
weeks before being discarded. 
 Plate cultures are examined every 1-3 days using a stereo microscope 
(x5-50 magnification).  Negative plates are discarded after 2-3 weeks (OIE, 
2000).  
 Colonial morphology varies with the medium used, the mycoplasma 
species, its passage level and the age of the culture. Mycoplasma species 
including strain F38 produce colonies of bizarre morphology in early 
passage, often small, centre-less and of irregular shape. With passage, such 
isolates demonstrate conventional “fried egg” colony morphology, except M. 
ovipneumoniae which remains centre-less in form. Colonies of Mmc and M. 
capricolum may reach up to 3 mm in diameter. 
Cloning and purification of isolates is performed by repeated transfer 
of single colonies representing each morphological type seen in/onto fresh 
media.  
 
1.5.2. Identification of the Mccp: 
1.5.2.1. Microscopic appearance:  
         The dark-field microscopy can be used to detect mycoplasma in 
 pleural fluids from diseased animals. Mccp and both M. mycoides 
 subspecies show a branching filamentous morphology in vivo. Abdulla 
 et al. (1967) developed a quick method for laboratory identification of                          
 CCPP in the Sudan.  The method allows the aspiration of the infected 
 pleural exudates from the infected goat by sterile syringe without 
 interfering in any way with subsequent treatment and recovery of the 
 animal.  
1.5.2.2. Cultural characteristics:  
  The slow growth rate and small colonies are characteristics of the 
fastidious Mccp and can be useful for primary identification. However, 
variation in cultural characteristics was observed (Bölske, 1995); strain 
4/2LC from Oman had a growth rate and colony size similar to many strains 
of M. capricolum.  
 
 
 
 
 1.5.2.3. Biochemical tests: 
 Biochemical tests are used for the initial grouping of mycoplasma. 
Sensitivity to digitonin differentiates cholesterol-requiring 
(Mycoplasmataceae and Spiroplasmataceae) from non cholesterol-requiring 
(Acholeplasmataceae) Mollicutes. The genus Mycoplasma can be 
differentiated from Ureaplasma by its lack of urease. Within the 
mycoplasmas of small ruminants, biochemical tests cannot unequivocally 
identify an isolate (Table 4) (Nicolas, 2002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4):  Biochemical characteristics of mycoplasmas of small 
ruminants  
  
Tetrazolium reduction  Mycoplasma Glucose 
fermentation  
Arginine 
hydrolysis
Phosphatase 
activity 
Film 
and 
spots
Casein 
digestion
aerobic anaerobic 
M.c 
capripneumoniae 
+/- - - - + Varies Weak/+ 
M.mycoides LC + - - - + + + 
M.m.capri + - - - + + + 
M.c.capricolum + + + - + + + 
M.ovipneumoniae + - - - - Varies + 
M.conjuctivae + - - - - - + 
M.agalactiae - - + + - + + 
M.putrefaciens + - + + - Varies + 
M.arginini - + - - - -  
 
+  : positive 
-   :  negative 
 
 
 1.5.2.4. Serology: 
1.5.2.4.1. Serological identification:  
 Serological tests are either used for identification of isolates (growth 
inhibition test and immunofluorescence) or detection of antibodies in goat 
sera. The role of the later group in diagnosis of CCPP is limited due to the 
fact that animals die in the acute stage of the disease before they develop 
antibodies. Accordingly, serology should be applied on a herd level, not on 
individual basis, and that whenever possible, paired serum samples collected 
3-8 weeks apart, should be examined. 
1.5.2.4.1.1. Immunofluorescence (IF) and growth inhibition (GIT): 
 Identification of mycoplasmas to species level has relied heavily on 
serological methods with antisera against whole mycoplasma cell. Mainly 
outer membrane antigens are detected with IF and GIT which explains their 
high specificity (Erno, 1983). These tests are therefore recommended for 
species identification of mycoplasma (Freundt et al., 1979; Subcommittee on 
the taxonomy of Mollicutes, 1979).  
1.5.2.4.1.2. Complement fixation test (CFT): 
 Complement fixation test was used for the detection of CCPP 
infection (MacOwan, 1976; MacOwan and Minette, 1977).  It was found to 
be more specific, though less sensitive, when compared to indirect 
haemagglutination test (Muthomi and Rurangirwa, 1983). Its main 
disadvantage is the high level of technical expertise required to perform the 
test. 
 
 
1.5.2.4.1.3. Polysaccharide-specific antibody detection latex 
agglutination test (LAT): 
 In this test, latex beads are sensitized with the polysaccharide 
produced by Mccp in culture supernatant. The reagent is then used in a slide 
agglutination test to detect antibodies (Rurangirwa et al., 1987). At present 
the test is routinely used in Kenya. It is a very useful test in outbreaks 
because it can be performed at the pen-side using a drop of whole blood.   
 Both CF test and IHA test findings emphasize the difficulties inherent 
in the serological diagnosis of CCPP when using whole cell or membrane 
antigen. The use of more defined antigen such as the polysaccharide 
provides greater specificity without cross-reactivity with sera against the 
other three principal caprine mycoplasmas. 
1.5.2.4.1.4. Indirect haemagglutination test (IHA): 
 The test was used for diagnosis of CCPP (Muthomi and Rurangirwa, 
1983). The specificity of this test for the M. mycoides cluster had been 
evaluated and results showed clear cross reactivity between these organisms 
(Jones and Wood, 1988).  Abbas et al. (1987) used membrane antigens of 
Mmm LC type, Mmc, Mccp and Mcc strains in IHA test and applied it in 
CCPP in infected and healthy goats in the Sudan. Among animals with signs 
of CCPP, 72% had antibodies to the two subspecies of M.Mycoides, but only 
7% had antibodies to M. capripneumoniae. 
1.5.2.4.1.5. Enzyme linked immunosorbent assay (ELISA): 
 Indirect ELISA was developed to screen goat sera at a single dilution 
of antibody to Mccp (WamWayi et al., 1989). The test was more sensitive 
than CFT in detecting antibodies in goat serum. Its specificity was not 
investigated, but the author reported that cross-reactivity in this test had been 
observed between Mccp and Mmm (SC) antigens. In attempts to overcome 
such inspecificity problems, a competitive ELISA (cELISA) was tried. The 
test was done using monoclonal antibodies (mAb) for the diagnosis of both 
CBPP (Abusurga et al., 1997; Goff and Thioucourt, 1998) and CCPP 
(Rurangirwa et al., 1997; Thioucourt et al., 1994). It has been described as a 
promising tool for the detection of CBPP and investigations are in progress 
to evaluate the test under the field conditions. Blocking ELISA was found 
also highly specific for CCPP and it detected antibodies in sera of naturally 
infected or artificially immunized animals while remained negative with 
hyperimmune sera to related strains such as PG 50 of Group 7 of Leach 
(Thioucourt et al., 1994). 
1.5.2.4.1.6. Polyacrylamide gel electrophoresis (PAGE) and 
Immunoblotting: 
 Whole-cell protein analysis by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis [SDS-PAGE] and/or Immunoblotting is 
widely used to characterize bacteria, including mycoplasma isolates (Costas 
et al., 1987; khan et al., 1987). The procedure is characterized by high 
specificity which allows the differentiation of distinct groups within a 
species.  
 For CCPP, Monoclonal Antibody to Mccp, designated E8-18, was 
tested against different strains in the Mycoplasma mycoides cluster with 
western blotting (Rurangirwa et al., 1997). E8-18 reacted with a 24-kDa 
antigen of Mccp but did not with any antigens of the other strains in the 
cluster. The identified antigen was found to be an integral protein on the 
surface of live Mccp. According to this finding, western blotting with 
monoclonal antibodies can be used in differentiating Mccp from closely 
related and difficult-to-distinguish Mycoplasma species. 
1.5.2.5. Molecular Biology: 
 In recent years, there has been a virtual revolution in methods for the 
detection of bacteria, viruses and other microorganisms, as a consequence of 
the use of new molecular biology techniques. 
 The PCR is an in vitro cyclic repetitive reaction which allows the 
amplification of a specific deoxyribonucleic acid (DNA) region that located 
between two regions of known DNA sequence (Newton and Graham, 1997). 
It was originally invented by a scientist called kary Mullis and described by 
Saiki et al. (1985) and Mullis and Fallona (1987). It was considered that the 
work of Saiki et al (1988) has greatly improved the technique.   
 A diagnostic method for CCPP based on PCR of the 16S rRNA genes 
from Mccp and restriction enzyme analysis of the PCR product has been 
developed (Ros Boscϋnana et al., 1994). The members of the M. mycoides 
cluster have two rRNA operons, designated rrnA and rrnB (Chrestiniansin et 
al., 1990); and the above diagnostic method for CCPP was based on a 
polymorphism (nucleotide difference between the two 16S rRNA genes in 
the same strain) which was found to be unique for Mccp. This polymorphism 
can therefore be easily used as a molecular marker for this subspecies, 
because it is localized in a restriction site for PstI (Ros Boscϋnana et al., 
1994). This unique polymorphism has been shown to be present in 16 strains 
of Mccp from different parts of the world, but it was not present in 39 strains 
representing other species or subspecies of the M. mycoides cluster. 
This system can be applied directly on various clinical samples to detect 
DNA from Mccp (Bölske, 1995).  It is proved to be useful for the diagnosis 
of CCPP and it has now been applied in identification of several Mccp 
isolates recovered from goats in many countries.  
1.5.2.6. Control and Prevention: 
Control of CCPP, as for any infectious disease, is based on the 
prevention of contact between the pathogen and the host, treatment of 
infected animals and increase the immunity of the host through vaccination. 
Isolation of infected animals, quarantine measurements and the 
application of sanitary methods are impractical to control the disease in 
Sudan generally due to nomadic nature of goat owners.   
1.5.2.7. Treatment: 
 Antibiotic treatment is an effective measure to eliminate the disease 
(Rurangirwa et al., 1981). Mycoplasma are naturally resistant to penicillin 
but sensitive to other antibacterial drugs e.g. streptomycin (Rurangirwa and 
Masiga, 1981), Teteracycline (Reverine) (Onovarian, 1974; Kansam, et al., 
1989) and Tiamulin (Aytug; Dikor and Demiroz, 1991).  
 Rurangirwa et al. (1981) carried out a detailed study on the treatment 
of CCPP. They demonstrated that one injection of dihydrostreptomycin 
sulphate at a dose 500-mg/kg body weights had a marked effect against 
experimentally and naturally infected goats. In the Sudan, El Nasri (1964) 
succeeded in treating goats affected by pleuropneumonia with tylosin at a 
dose of 3mg/1b body weight. 
 Antibiotic treatment however, remains impracticable due to many 
reasons. Antibiotic therapy commonly provides a rapid improvement of the 
clinical picture and, in individual and sporadic cases, may cure the infection. 
On herd bases however, systemic treatment of all animals, as the only 
control measure would be very uneconomical.  
1.5.2.8. Vaccination: 
 An inactivated vaccine with saponin as an adjuvant was produced in 
Kenya following a series of trials (Rurangirwa et al., 1991). The vaccine was 
proved to be effective in the field and protects animals for approximately 
one year. 
 
 
 
                                                                                                        
 CHAPTER TWO 
 
MATERIALS AND METHODS 
 
2.1 Glassware: 
Glassware used in the study includes bottles, flasks of different size, 
test tubes, Petri dishes, pipettes, glass rods …etc.  
For preparation, all glassware were soaked for a short time in warm 
10% detergent solution, scrubbed, rinsed at least three times in running 
warm water, followed by rinsing in distilled water. They were then put on 
clean surface to drain and dry. Pipettes were put in liquid detergent solution 
overnight and then washed by tap water for at least two hours followed by 
rinsing in distilled water. Flasks, test tubes and pipettes were plugged again 
with cotton wool and put in special container. Petri-dishes were stacked in a 
metal can with cover side upper most and sterilized.  
Graduated and capillary pipettes, petri dishes, forceps, scissors and 
needles were sterilized in oven at 160 ºC for 2 hours. Bottles with plastic 
cups (Bijou, universal, and medium bottles) and Seitz-filter were sterilized 
by autoclaving at 121ºC for 15 minutes. 
2.2 Samples: 
Pneumonic lung tissues, adjacent lymph nodes and serum samples 
were collected from South Darfour, Khartoum, Kassala and red sea states. 
Collection of samples was carried out during winter and rainy seasons 
between September 2003 – March 2005 (Table 5). 
 
(Table 5): Samples collected from different Sudan states for the survey of 
CCPP. 
Time of 
collection 
No. of 
samples
Type of samples Place 
October – 
November  2003
 
 
245 
 
 
5 
248 
Pneumonic lung
tissue and adjacent 
lymph nodes
pneumonic lung
Goat serum
S. Darfur state: 
(1) slaughter 
house 
samples: 
 
(2) field samples 
March 2005 
24 
 
 
 
1 
150 
Pneumonic lung
tissue and adjacent 
lymph nodes
pneumonic lung
 Goat serum
Khartoum state: 
(1) slaughter 
house samples: 
 
 
(2) field samples: 
 
October 2004 
23 
 
 
 
1 
65 
Pneumonic lung
tissue and adjacent 
lymph nodes
pneumonic lung
 Goat serum
Kassala state: 
(1) slaughter 
house samples: 
 
 
(2) field samples 
Red Sea state: 
(1) slaughter 
house samples: 
 
 
(2) field samples 
Pneumonic lung
tissue, adjacent lymph 
nodes.
Goat serum
 
17 
 
 
 
50 
 
August 2005 
 
  
 
In slaughter house, samples were taken from all lungs showed 
pneumonia. Apiece of pneumonic lung (5cm3) and adjacent lymph nodes 
were placed in nylon bag and labeled. All samples were transported to the 
laboratory in thermos flask containing ice cubes soon after collection and 
stored at -20ºC. 
In the field, samples were taken from goats showed typical clinical 
signs of contagious caprine pleuropneumonia. 
Serum samples were collected randomly from goats that represent 10-
20 % of a flock. Ten ml of blood samples were aspirated from the jugular 
vein in sterile vacutainers. Samples were left for one hour at room 
temperature then kept overnight in refrigerator. Sera were then aspirated 
with sterile pipettes, placed in sterile test tubes and centrifuged at 3000 rpm 
for 10 minutes. Samples were then stored in final containers at -20ºC.   
2.3 Culture media: 
2.3.1 Media for isolation and cultivation of Mccp: 
2.3.2 Media ingredients: 
2.3.2.1 Glucose solution:  
 Fifty grams of glucose were dissolved in 100 ml distilled water, sterilized 
by autoclaving at 108ºC for 5 minutes and then stored at 4ºC until used. 
2.3.2.2 Penicillin solution: 
 It was prepared by dissolving Benzyl penicillin sodium powder (one 
million IU) in five ml sterile distilled water to give 200,000 IU/ml and stored 
at 4ºC. 
 
 
2.3.2.3. Fresh yeast extract:  
 Two hundred and fifty grams of pure fresh yeast extract were added to 
one liter of distilled water, heated at 100ºC for 30 minutes and then 
centrifuged at 6000 rpm for 10 minutes. The supernatant was then separated, 
sterilized by filtration through cellulose acetate filter (0.2 µm pore size, 
Sartorius) and stored at -20ºC until used. 
2.3.2.4. Thallium acetate 10% (w/v):  
 This solution was prepared by dissolving 10g of thallium acetate in 100 
ml of distilled water, sterilized by autoclaving at 121ºC for 15 minutes then 
stored at 4ºC till used. 
2.3.2.5 Phenol red 0.06% (w/v) solution:  
 An amount of 0.6g of phenol red was dissolved in 100ml of distilled 
water. One ml of this solution was added to nine ml of distilled water, 
sterilized by autoclaving at 121ºC for 15 minutes and stored at 4ºC.   
2.3.2.6 DNA 0.2 % solution:- 
 An mount of 0.2g of Deoxyribonucleic acid sodium (Salman / Horring 
salt (Ube chem) was dissolved in 100 ml distilled water, sterilized by 
filtration and distributed in 10 ml amounts. 
- 2.3.2.7 Horse serum:  
 Twenty percent trisodium citrate was prepared in blood collection Bottles. 
The blood was collected aseptically from the jugular vein of a healthy horse. 
It was put overnight on the bench. The plasma was separated and measured. 
Then 10% calcium chloride was added to separate fibrin and the serum was 
heated in water bath at 56ºC for half an hour to destroy the complement. 
Serum was then sterilized by filtration through cellulose acetate filter (0.2 
µm pore size, Sartorius). Aliquoteus of 50 and 100 ml of serum was 
prepared aseptically and put in the refrigerator at 4ºC until used. 
2.3.3 Brucella medium: 
Part A:  
Bacto Brucella broth (Difco) 28.0 g
Yeast extract (Difco) 1.0 g
Distilled water 750 ml 
Part B:  
Glycerol   10 ml 
Horse serum 240 ml 
Penicillin 200,000 I.U/ml 0.5 ml      
Thallium acetate 10% 0.3 ml 
                                                                     
 Part A was dissolved by heating. The pH was adjusted to 7.6, then the 
medium was sterilized by autoclaving at 121ºC for 15 minutes. Part B was 
then added aseptically to part A at 50ºC. The medium was gently mixed and 
distributed in 5 ml amount into sterile test tubes. To check sterility, the 
medium was incubated at 37ºC over night, then stored at 4ºC and used 
within four weeks.   
 For solid media, 43g of Brucella agar base was added to part A 
instead of brucella broth. The medium was then prepared as described for 
brucella broth and distributed in 15ml amount into sterile petri dishes.             
 
 
 
 
 
2.3.4 Modified Hayflick's medium:  
 The medium was used as described by Thiaucourt et al. (1996) with 
one modification by addition of dehydrated commercial yeast extract. 
 Part A:  
PPLO broth w\v crystal violet (Difco) 21.0 gm 
Yeast extract (Difco) 5.0 gm 
Distilled water 700 ml  
Part B:   
Horse serum 200 ml 
Fresh yeast extract 100ml 
Glucose (0.5 g/ml) 2.0ml 
Sodium pyruvate (0.5 g/ml) 8.0ml 
Penicillin 0.5ml  
Thalium acetate (105). 0.3ml 
Sodium pyruvate (0.5 g/ml) 8.0 ml 
                                                            
 Part A was dissolved by heating. The pH was adjusted to 7.6, and then 
the medium was sterilized by autoclaving at 121ºC for 15 minutes. Part B 
was then added aseptically to part A at 50ºC. The medium was gently mixed 
and distributed in 5 ml amount into sterile test tubes. To check sterility, the 
medium was incubated at 37ºC overnight, then stored at 4ºC and used within 
four weeks.                                                                                        
 For solid media and after addition of part B to part A, agar (Oxoid) 
was dissolved by heating, sterilized by autoclaving at 121ºC for 15 min and 
then added to broth medium at 50ºC to give final concentration of 1.5%. The 
medium was then poured aseptically in 15 ml amounts into sterile petri 
dishes.  
2.3.5 Media without antibiotics:- 
 Solid media without antibiotics were prepared by omition of 
inhibitors. 
2.3.6 Media for Biochemical tests: 
2.3.6.1 Glucose fermentation medium:  
Part A:   
Heart infusion Broth. 3,33g 
Distilled water. 90ml.  
Part B:  
Horse serum 20ml 
DNA (0.2% (w\v) solution) 1,2ml 
Phenol red (0.6 %) 5ml 
Thallium acetate (10% (w\v)) solution 0.25ml 
Penicillin (200,000 I.U. per ml) 0.25ml 
Glucose (50%) 1ml 
PH 7.3. 
The medium was prepared as described for Brucella broth. 
 
2.3.6.2 Arginine test medium:   
Part A:  
Heart infusion broth 180 ml 
Part B:  
Horse serum. 40 ml 
Yeast extract (25% w/v suspension) 20 ml 
DNA stock solution (0.2%w/v) 2.6 ml, 
Arginine monohydrochloride (30% w/v solution) 8.5 ml 
phenol red (1%w/v Solution) 5 ml 
The medium was prepared as described for brucella broth.  
                                                 
2.3.6.3 Tetrazolium reduction medium:  
Part A:  
Heart infusion broth 180 ml 
Part B:  
Horse serum. 40 ml 
Yeast extract (25 %w/v suspension) 20 ml 
DNA stock solution (0.2%w/v) 2.6 ml 
Triphenyltetrazolum chloride (2% w/v solution) 
The medium was prepared as described for brucella broth. 
 
5 ml 
2.3.6.4 Phosphatase test medium:   
Part: A  
 Phosphatase agar  medium 74 ml   
Part: B  
Horse serum (inactivated at 56ºC) 20 ml 
Yeast extract (25%w/vsuspention) 5ml 
Penicillin (200 000 IU/ml) 0.2ml   
Phenol nephthaline sodium diphosphate (1% w/v) solution 1ml 
 
The medium was prepared as described for Brucella agar. 
 
2.4 Cultivation of samples:- 
 Tissue samples were chopped with scissors then shaken vigorously in 
broth media with antibiotics, using 1g of tissue to 9ml of medium. Then the 
mixture was diluted through at least three ten-fold steps in the same medium 
broth. All broth cultures and dilutions were streaked on solid media (OIE, 
1991).  
 Broth cultures were incubated at 37ºC for 3 -7 days and examined 
every two or three days for evidence of growth and to ensure the absence of 
bacterial contamination. Plate cultures were incubated at 37ºC in a 
humidified atmosphere in a candle jar for 3-15 days.  
2.4.1 Detection of growth: 
 The fine turbidity that developed after a weak of incubation was 
regarded as primary sign of growth. Wet mounts were prepared and 
investigated under dark field microscopy. Solid media were investigated 
using low power of light microscope for fried-egg type of colonies. 
Isolates were streaked on solid media without antimicrobials to exclude the 
L-form of bacteria. 
2.4.2 Purification and storage of isolates:  
 Well-separated colony was used to inoculate fresh solid medium. 
Subcultures were repeated twice before the isolates were said to be pure. 
Then a colony of an isolate was cut and placed in broth media and stored 
frozen at -20ºC. For longer storage pure isolates were stored in a lyophilized 
state. 
2.5 Identification of isolates: 
2.5.1 Microscopy: 
 It was used for initial detection of mycolasma in broth culture and to 
exclude bacterial contamination. Wet mounts of broth cultures were 
examined by dark field microscope for mycoplasma filaments. 
2.5.2 Cultural Characteristics: 
 Growth of isolates on liquid and solid media was fully described. 
2.5.3 Biochemical tests: 
 These tests were used for the initial grouping of the isolates. 
2.5.3.1 Digitonin activity: 
 The test was used according to Tully (1983). 
2.5.3.1.1 Materials: 
- Broth cultures of the isolates. 
- Digitonin stock solution, 95% ethanol and filter disks (6mm in 
diameter). 
- Solid mycoplasma media. 
- Screw-caped bottles. 
2.5.3.1.2. Method: 
 Fifty five ml of digitonin stock Solution (1.5% w/v) was added to five 
ml of 95% ethanol in screw-caped bottles. This solution was heated gently in 
boiling water to dissolve the digitonin completely. It was then stored at 4ºC 
until used. Filter paper disks were placed in sterile petri dish and 0.025ml of 
digitonin solution was added to each disk, dried over night at 37ºC and then 
stored at 4ºC until used (Tully, 1983). 
 The solid medium was inoculated by the drop technique. The 
inoculum was placed on the medium surface and allowed to run in one 
direction. Then a disk of digitonin was placed aseptically on the line of the 
inoculated culture and the plate was incubated aerobically at 37ºC for 3-15 
days. Disappearance of growth only around the disk indicated the sensitivity 
of isolates to digitonin. 
 
2.5.3.2 Glucose fermentation:  
 Broth media were inoculated with the isolates under test. Cultures 
were then incubated at 37ºC for 3-15 days. Positive result was indicated by 
change of color from red to yellow. 
2.5.3.3 Arginine Hydrolysis:  
 The broth medium was inoculated with the test culture and incubated 
at 37ºC for 3-15 days. A positive reaction was indicated by change of 
medium color to deep purplish-red.  
2.5.3.4. Teterazolium reduction:  
 The broth medium was inoculated with the test culture and incubated 
aerobically at 37ºC for 10 days. A positive result was indicated by the 
development of a brick-red coloration in the test medium and no change of 
color in negative control. 
2.5.3.5 Phosphatase activity:  
A plate of phosphatase agar medium was inoculated with 0.2 ml broth 
culture and incubated in a moist chamber at 37ºC for 5-10 days. The plate 
was then examined with stereo microscope for the appearance of 
mycoplasma colonies. When the colonies were clearly visible (usually on 
day 6 of incubation), 1ml of 40% solution of NaOH or KOH was poured. A 
positive phosphatase activity was indicated by the appearance of a pink-red 
coloration around the mycoplasma colonies within 30 seconds upon the 
addition of the alkaline solution.  
2.5.4 Serological tests: 
2.5.4.1 Growth Inhibition test: 
 The test was used as described in OIE manual (1991) with one 
modification by using the running drop technique. 
 
2.5.4.1.1 Materials: 
-  Broth culture of mycoplasma isolates under test. 
- Goat hyperimmune sera against Mccp, strain F38 (CIRAD, 
 France). 
- Brucella solid media. 
- Sterile paper disks (6-7 mm diameter). 
- 1 ml sterile glass pipettes. 
2.5.4.1.2 Method:  
 The running drop technique was used. A drop of culture was pipetted 
onto the solid medium and allowed to run in one direction. After drying, 
freshly impregnated disks with 15µl hyper immune serum was placed on the 
agar on the inoculation line. Plates were then incubated microaerobically for 
7-10 days in humidified container. The test was regarded as positive when 
an inhibition zone of 2 mm or more around the disc was obtained. 
2.5.4.2 Complement fixation test: 
 The test was done as described by Thiaucourt et al. (1996)  
2.5.4.2.1 Materials: 
2.5.4.2.1.1 Test sera:  A total of 513 serum samples (table 5). 
2.5.4.2.1.2 CFT solutions: 
2.5.4.2.1.2.1 Elsevier's Solution:   
This solution was used for the preservation of sheep red cells. It consisted 
of:  
Glucose   8.66 g 
Sodium chloride 4.18 g 
Sodium citrate 8.00 g 
Citric acid 0.55 g 
Distilled water 1000 ml 
 
2.5.4.2.1.3 Buffers:  
2.5.4.2.1.3.1 Veronal buffer (VB): 
 This buffer was used to dilute the reagents used in the complement 
fixation test. It consists of the following ingredients:   
-  Sodium chloride  8.50  g  
-  Diethylmalonylurea (Barbital) 0.575 g 
-  Diethylmalonylurea, sodium salt 0.185 g 
-  Calcium chloride (anhydrous) 0.028 g 
-  Magnesium chloride (6H2O) 0.168 g 
-  distilled water 1000 ml  
                                                      PH 7.4  
 
2.5.4.2.1.4 Reagents: 
2.5.4.2.1.4.1 Antigen:  
 This was an inactivated antigen, consisting of washed mycoplasma 
cells ( Gabes strain) that were boiled, lysed and freeze-dried. It was 
reconstituted with distilled water and kept at -20°C.  
2.5.4.2.1.4.2 Guinea pig complement: 
 A commercial freeze dried complement produced by BioMérieux 
(FRANCE) was used.  
2.5.4.2.1.4.3 Sheep red blood cells (SRBC): 
 Fresh SRBC was obtained and stored in Alsever solution (50%). It 
was used after storage at 4°C for at least 2 days. Before use, SRBC was 
washed by centrifugation three times in VB (1 volume of SRBC for 9 
volumes of VB) at 700g for 5 minutes. 
2.5.4.2.1.4.4. Hemolytic serum: 
 It was diluted according to the producer (BioMérieux, FRANCE).  
2.5.4.2.1.4.5 Reference sera: 
 It was obtained from a freeze dried reference serum of sheep origin. It 
was reconstituted with 1 ml sterile distilled water. Once reconstituted, it 
was kept at -20°C. 
Devices:- 
 Incubator, water bath, refrigerator, monochannel and multichannel 
micropipettes (10-100µl) and U-shaped bottom microplates.  
2.5.4.2.2 Method: 
- The test sera (heat inactivated at 56°C for 30 minutes) were 
examined in duplicate beginning from row A. They were first 
diluted 1/10 in veronal buffer (90µl of VB + 10µl tested serum). 
Wells 1 and 2 in row A were left for positive control which was 
diluted as test sera. 
- The remained wells were filled with 25 µl of VB except that of 
row B which were left empty. Instead, 50µl were transferred from 
A-row to B-row. 
- 25µl were transferred from row B to the row C. This step was 
repeated (doubling dilution) to all other rows and at the end 25µl 
was discarded. 
- 25µl of diluted antigen was added to all wells except that in row A 
for anti complementary reaction. 
- 50µl of the diluted complement was added to all wells. 
- The plates were incubated at 37°C for one hour with shaking. 
- 25µl of the haemolytic system which was prepared according to 
the titer was added to all wells. 
- The plate was incubated for one hour at 37ºC with shaking. 
- Reading the results: the plate was read after centrifugation or after 
being left in the refrigerator (4°C) over night. The titre was 
determined as the highest serum dilution that fixes 50% of the 
complement. 
 
2.5.5 Nucleic acid techniques:  
2.5.5.1 Polymerase chain reaction: 
 The test was done according to Bölske et al. (1996). 
2.5.5.1.1 DNA Extraction:  
2.5.5.1.1.1 Materials: 
Broth cultures of Mycoplasma isolates. 
Reagents and solutions: 
- Phosphate buffered saline (PBS). 
- DNA hydration solution (Amersham Biosciences). 
Equipments: 
- Refrigerator (4ºC) and Deep freezer (-20ºC up to -80ºC).  
- Heating block (TB1 Termoblock, Biometra, Germany). 
- Automatic pipettes of different volumes and suitable tips.  
- Vortex mix and plastic gloves. 
2.5.5.1.1.2 Methods: 
 Three different DNA extraction methods were used to isolate genomic 
DNA from broth culture of Mycoplasma isolates. 
- The first method was described by Bölske et al. (1996). 1ml broth 
culture of the Mycoplasma isolate was centrifuged at 12000g for 20 
min., washed in PBS, re-suspended in 1ml distilled water and lysed by 
being heated at 100ºC for 10 min.     
- The second extraction method was done as described by Zakia (2005). 
1ml of broth culture was centrifuged at 12,000g For 15 min, 
resuspended in 1ml D.D.W and lysed by being heated at 100ºC for 20 
min.  
- Kit method: 200µl of broth culture, 200µl D.D.W and 400 µl ethanol 
(absolute) were mixed and centrifuged at 12.000g for 10 min. The 
supernatant was re-suspended in DNA hydration solution (50 µl). 
2.5.5.1.2 Amplification of the extracted DNA: 
2.5.5.1.2.1 Materials: 
Reagents and solutions: 
- Taq DNA polymerase (Amersham Biosciences) 
- Primers (Amersham Biosciences): 
Forward Primer 5´ CGA AAG CGG CTT ACT GGC TTGTT 3´  
Reverse Primer 5´ TTG AGA TTA GCT CCC CTT CAC AG 3´  
- Deoxynucleoside Triphosphate (DNTPs) (Amersham Biosciences) 
- MgCl2 (Amersham Biosciences) 
- 10 x reaction buffer. 
Equipments: 
- Automatic pipettes of different volumes and suitable tips and PCR 
tubes. 
   -    Thermocycler machine (TP3, Biometra, Goettinen, Germany) 
2.5.5.1.2.2. Method:  
 The amplification was performed as described by Bölske et al (1996). 
It was carried out with 50 µl reaction mixture. The reaction mixture 
consisted of 5µl 10xPCR amplification buffer, 5µl Triton x (1% ), 1µl 
(DNTPs), 2µl MgCl2, 2µl of each Primer (100Pmol /µl), 5µl sample 
containing template DNA, 1µl Taq DNA polymerase and 27 µl distilled 
water to a final volume of 50µl.  
 Amplification consisted of 31 cycles comprising 45s denaturation at 
95ºC, 1 min annealing step at 62ºC, 2 min elongation step at 72ºC and 3 min 
elongation step at 72ºC. 
2.5.5.1.3 Analysis of PCR product: 
2.5.5.1.3.1 Materials: 
- Agarose 1.5% (app.6.1). 
- DNA tracking (Loading Dye) (app.6.2). 
- Ethidium bromide (app.6.3). 
- Running buffer (TAE buffer) (app.6.4). 
- Standard DNA molecular weight marker (ladder) (app.6.5). 
2.5.5.1.3.1.1 Equipment: 
- Standard power pack (P25, BIOMETRA). 
- -Mini Gel electrophoresis (BIOMETRA). 
- Gel documentation system (BIODOG ANALAYZ, BIOMETRA, 
Germany). 
2.5.5.1.3.2 Method: 
 The PCR products (amplicons) were separated electrophoritically in 
1.5% agarose gel containing ethidium bromide(1µl/40 ml agarose).10 µl 100 
bp DNA ladder were loaded in the first slot of gel. Then 10 µl of PCR 
product were mixed with 5 µl of loading dye and loaded on the wells. 
 Electrophoresis was performed in mini Gel electrophoresis using 75 
volt for 45 minutes after the gel was covered with TAE buffer. DNA bands 
were detected and photographed using the gel documentation system.  
 
2.5.5.1.4 Restriction enzyme analysis of the amplified DNA: 
 The method was used as described by Bölske et al. (1996). 
2.5.5.1.4.1Materials: 
2.5.5.1.4.1.1 Reagents and solutions: 
1-  PCR product. 
2-  Pst1 (1.5-5µl) (Amersham Bioscience). 
3-  Reaction buffer (Amersham Biosciences). 
2.5.5.1.4.2 Method: 
 Without further purification, the amplified DNA was digested with 
Pst1 in One-phor-all buffer (Amersham Biosciences) at 37ºC for 2 hrs, and 
the resulting products were analyzed by agarose gel (2%) electrophoresis as 
previously described. 
CHAPTER THREE 
 
3. RESULTS 
 
3.1 Isolation of Mycoplasma: 
Isolation of Mycoplasma from pneumonic lung tissue samples is 
illustrated in tables (6) and (7). The isolation percentage was only 2.6% 
(seven isolates from 298 samples collected). Five isolates were recovered 
from southern Darfur and two were recovered from Khartoum and Kassala 
states.  
3.1.1 Samples collected from Southern Darfur State: 
3.1.1.1Field samples: 
 Samples were collected from 5 animals showing clinical signs of the 
disease in Nyala town and its surroundings. Examined animals showed 
fever, increased body temperature (40-42°C), dullness and muco-purulent 
discharge emerged from the nostrils. Breathing was difficult and mostly 
abdominal with painful grunting. One goat was Saanin (foreign breed) which 
stood opening its mouth and abducting hind limbs (Fig. 1: a and b). 
 Post-mortem examination revealed restriction of lesions to the 
thoracic cavity. Lesions include hepatization of the lung mostly the right 
apical lobe (fig. 2: a and b). Adhesions of the lungs to the chest cavity and 
increased pleural fluid were not detected. 
 A mycoplasma was isolated from the foreign breed goat. The isolate 
was designated as Nyala 2 (N2).  
 
Table (6): Primary isolation of Mycoplasma using different culture 
media: 
Growth of isolates in/on different culture 
media 
Brucella medium Hayflick’s medium 
Mycoplasma 
isolates 
Location 
Broth agar broth Agar 
N2 Nyala + + + + 
N3 Nyala + Nil + Nil 
N4 Nyala + Nil + Nil 
N5 Nyala + Nil + Nil 
N9 Nyala + Nil + Nil 
Kh6 Khartoum + Nil + + 
Ka1 Kassala + Nil + Nil 
 
 
Table 7: Isolation of mycoplasma from tissue samples 
Location No. of samples No. of isolates Percentage 
Nyala 250 5 2% 
Khartoum 25 1 4% 
Kassala 23 1 4.1% 
Total 298 7 2.6% 
 
 
 
3.1.1.2 Slaughterhouse samples: 
 245 pneumonic lung tissue samples were collected from 
slaughterhouse in Nyala town and cultured in Brucella and Hayflick΄s 
media. Four mycoplasma isolates were recovered from these samples. They 
were designated Nyala 3 (N3), Nyala 4 (N4), Nyala 5 (N5) and Nyala 9 
(N9).  
3.1.2 Samples collected from Khartoum State: 
3.1.2.1 Field samples: 
 Samples were collected from a goat showed typical clinical signs of 
the CCPP in Hilat Kuku area, Khartoum North. In Post mortem examination 
extensive fibrinous pleuropneumonia was detected. A mycoplasma was 
isolated from that goat and designated Khartoum 6 (Kh6). 
3.1.2.2 Slaughterhouse samples: 
 24 pneumonic lung tissue samples were collected from Elkadaro 
slaughterhouse in Khartoum North. Cultivation of these samples in suitable 
media for mycoplasma revealed no growth.  
3.1.3 Samples collected from Kassala state: 
3.1.3.1 Field samples: 
 Samples were collected from a goat showed typical clinical signs of 
the CCPP in Kassala State. Post mortem findings showed lesions of 
pleuropneumonia. A mycoplasma was isolated from that goat and designated 
Kassala 1 (Ka1) 
 
 
 
3.1.3.2 Slaughter house samples: 
 23 pneumonic lung tissue samples were collected from Kassala State. 
Cultivation of these samples in suitable media for mycoplasma revealed no 
growth.  
3.1.4 Samples collected from Red Sٍea state:  
3.1.4.1 Slaughter house samples: 
 17 pneumonic lung tissue samples were collected from Red Sea state. 
Cultivation of these samples in suitable media for mycoplasma revealed no 
growth. 
3.2 Identification of mycoplasma isolates:  
3.2.1 Cultural characteristics:  
3.2.1.1 Darfur state isolates: 
 The growth characteristics of the isolates in/on Brucella and Hayflicks 
media are shown in table (6). All isolates grew in broth media forming fine 
turbidity after three days of aerobic incubation at 37Cº. Nyala2 was isolated 
in Brucella medium (broth and solid) without sodium pyruvate but it grew 
also good in Hayflick΄s medium with sodium pyruvate. Nyala 2 grew on 
solid media with or without bacterial inhibitors forming the typical fried-egg 
type of colonies after 10-14 days (figure 3: a and b).  
 Isolates designated N3, N4, N5, N9 were primarily isolated in both 
Brucella and Hayflick´s solid media. Colonies were similar to that of N2 on 
both media. However, subcultures from solid and broth onto solid media 
were always unsuccessful.  
 
 
3.2.1.2 Khartoum State isolate: 
 The isolation of Kh6 was achieved in both Brucella and Hayflick´s 
medium. In broth media, the growth appeared after 3 days of aerobic 
incubation but on solid media colonies appeared primarily after 10 – 14 days 
of incubation. Colonies on media containing sodium pyruvate were 
comparatively larger than that obtained on media without sodium pyruvate 
(figure 4). Subcultures from solid or liquid medium to solid media were 
always unsuccessful. 
3.2.1.3 Kassala State isolate: 
 The isolation of Ka1 was achieved in both Brucella and Hayflick´s 
medium (broth and solid).The isolate grew aerobically in broth media 
forming fine turbidity after three days of incubation at 37Cº. On solid media 
colonies appeared after 10-14 days of incubation. Subcultures from solid or 
liquid medium to solid media were always unsuccessful. 
3.2.2 Biochemical characteristics: 
Results of biochemical tests for all mycoplasma isolates are shown in Table 
(8). The isolates gave biochemical reactions similar to that produced by 
Mycoplasma capricolum subsp. capripneumoniae.  
 
 
 
 
 
 
 
Table 8: Biochemical characteristics of Mycoplasma isolates: 
 
Isolates 
No 
Glucose 
fermentation 
Tetrazolium 
reduction 
Arganine 
hydrolosis
Digitonin 
test 
Phosphatase 
activity 
(aerobic) 
N2 + - - + - 
N3 + - - + ND 
N4 + - - + ND 
N5 + - - + ND 
N9 + - - + ND 
Kh6 + - - + ND 
Ka1 + - - + ND 
 
(+):  Positive 
(-):  Negative 
ND:  not done 
 
 
 
 
 
 
 
 
 
3.2.3 Serological identification: 
3.2.3.1 Growth inhibition test: 
The test was carried out only for the isolate N2 and it gave positive 
result (Fig. 5). Other isolates were not tested due to the fact that growth on 
solid media was always unsuccessful. 
3.2.3.2 Complement fixation test (CFT): 
 
Five-hundred and thirteen goat sera from the four states surveyed in 
this study were screened for antibodies against Mccp using CFT as described 
in OIE Manual (1991). Results are shown in table (9). Antibodies against 
Mccp were detected in 33.5% of samples obtained from Southern Darfur 
state, from 30% of samples obtained from Khartoum state, 38 % of samples 
from Kassala state, and from 36 % of samples obtained from Red Sea state. 
Higher antibody titres were detected in sera from southern Darfur 
state while low titres were detected in Khartoum and Kassala states. 
 
 
 
 
 
 
 
 
 
 
   
Table (9): Detection of antibodies against Mycoplasma capricolum subsp. 
caprineumoniae in serum samples by complement fixation test (CFT). 
 
Positive 
Titres 
location Total no 
of 
serum 1/10 1/20 1/30 1/40 1/50
Percentage 
of positive 
sera. 
negative
samples 
Positive 
control 
+ + + + +   
Negative 
control 
- - - - -   
S. Darfur 
state 
248 51 13 10 6 3 
(83) 
33.5% 
165 
Khartoum 
state 
150 45 - - - - 
(45) 
30% 
105 
Kassala 
state 
65 25 - - - - 
(25) 
38% 
40 
Red Sea 
state 
50 18 - - - - 
(18) 
36% 
32 
 
total 
513 139 13 10 6 3 
(171) 
33.3% 
342 
 
3.2.4 Polymerase chain reaction-restriction enzyme analysis (PCR-
REA): 
 The DNA from the seven Mycoplasma isolates was subjected to PCR 
analysis as described by Bölske et al. (1996). After amplification, all isolates 
gave one band at 548-bp indicating that the isolates belonged to the 
members of the Mycoplams mycoides cluster (fig.6). Lanes 1, 2 and 3 
showed amplified DNA of isolate N2 extracted by different methods 
(2.5.5.1.1.2). Clear bands were detected in lanes loaded by amplified DNA 
extracted by Zakia (2005) method (lane one) and Bölske et al. (1996) 
method (lane 3). 
 Restriction enzyme analysis (REA) using Pst1 was tried for the isolate 
N2. No results were obtained due to defect in the enzyme. Further analysis 
of Nayla2 was carried in CIRAD, France. Three bands were obtained at 548, 
420 and 128 bp indicating that the isolate was Mycoplasma capricolum 
subsp. capripneumoniae (Fig.7).  
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Fig. (1) a & b: A Saanin goat shows typical clinical signs of CCPP (S. Darfur, Nyala). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2:a Pneumonic lung of the affected animal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: b  Hepatization of the right apical lobe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 a: Mccp (isolate N2) on Mycoplasma media after 10-14 days   
 incubation (Mag. 10x10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 b: M. capricolum subsp. capripneumoniae (Nayla2) isolated on Brucella agar after 
10 days incubation (Mag. 10x10) 
 
 
 
 
 
 
 
Fig (4 )  Large colonies of isolate Kh1 on Hayflicks medium after 10 days   
 incubation (mag. 10x10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4   Large colonies of isolate Kh1 on Hayflick´s medium after 10 days   
 incubation (Mag. 10x10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Fig. 5  Growth inhibition test for isolate N2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6): Electrophoresis patterns of amplified DNA extracted from the isolates N2 (lanes 
1, 2 and 3 by 3 different DNA extraction methods), N3 (lane 4), N4 (lane 5), N5 (lane 6), 
N9 (lane 7), Kh6 (lane 8) and Ka1 (lane 9). Molecular weight markers are indicated in 
lanes M. 
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Fig. (7): Restriction enzyme analysis with Pst1 of amplified DNA obtained from isolate 
N2 (lanes 2 & 3), positive and negative control (lane 4 & 5 respectively) and molecular 
weight marker (lane one),  
. 
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 CHAPTER FOUR 
 
DISCUSSION 
 
Contagious caprine pleuropneumonia (CCPP) is a major disease of 
goats in Africa, Middle East and Western Asia. It is highly a contagious 
disease with up to 100% and 70% morbidity and mortality rates in 
susceptible herds respectively. The disease, which is caused by Mycoplasma 
capricolum subsp. capripneumoniae (Mccp), results in major economic 
losses to goat industry in nearly 40 countries; hence it is placed by the OIE 
in list B, which includes the important diseases from economic standpoint.  
While clinical disease has so far been reported in 38 countries, only 
11 countries have isolated the causative organism, principally because Mccp 
is difficult to culture. In the Sudan, the disease is known as Abu nini and it 
was described in the Sudan Veterinary Reports since 1902 (Anon, 1902). 
However, isolation attempts of the causative agent were unsuccessful till 
1960s when Abdulla and Lindly (1967) achieved the primary isolation of a 
mycoplasma from a goat with pleuropneumonia, but they failed to maintain 
the isolate. The presence of the disease in the Sudan was officially declared 
in 1981 following the successful isolation of the type strain (F38) from a 
goat showing signs of Abu nini in Khartoum State (Harbi et al., 1981). 
Thereafter, diagnosis of the disease in the Sudan was based mainly on 
clinical signs and postmortem findings.  
Failure to isolate more strains in the Sudan in the last 22 years 
resulted in lack of data concerning the characteristics of local strains 
responsible for the disease; their origin and distribution in the country, and 
their immunogenic properties which would facilitate diagnosis and help in 
the formulation of a suitable vaccine (mono-or multivalent) to control CCPP 
in the Sudan. 
 The present research work was carried out to study the distribution of 
the disease in some of Sudan States (Southern Darfuor, Khartoum, Kassala 
and Red Sea states) and to provide recent field isolates which will help in 
epidemiological studies and control programs using a suitable 
immunological agent. 
Results of this study revealed the isolation of only seven mycoplsasma 
out of 316 samples investigated. This could be explained by the fact that 
most pneumonic lung tissue samples were obtained from slaughterhouses 
and collected from any pneumonic goat lung. Intern the percentage of 
isolation of mycoplasma from field samples was bigger (37.5%, 3 isolates 
out of 7 samples) and this was owed to the fact that samples were taken from 
animals showing typical clinical signs of CCPP. 
Identification of mycoplasma isolates was carried out using standard 
procedures. The culture characteristics of the isolates (slow growers) were 
similar to that of Mycoplasma capripneumoniae. Both Brucella and 
Hayflick΄s media supported the primary isolation of the mycoplasma. All 
isolates grew on media without sodium pyruvate (Brucella medium). The 
addition of sodium pyruvate enhanced the growth of some isolates which 
gave larger colonies on Hayflick΄s agar (strain Kh1). This finding illustrated 
that the recovered mycoplasma in this study didn’t depend on sodium 
pyruvate to grow. However, addition of this ingredient may enhance the 
growth. Similar results were obtained by Abu-Groun et al. (1994) and 
Harrison et al. (2000). The later studied 11 strains of Mccp and found that 6 
of the strains were able to grow in the absence of pyruvate while the other 5 
strains grew only upon the addition of pyruvate. In another study, Zaki 
(2001) studied the growth of strain Gabes in the bioreactor. He found that 
the gradual addition of sodium pyruvate to the medium in the bioreactor 
affects the growth positively. He also observed that Gabes strain grows on 
Hayflick΄s agar containing pyruvate producing large colonies (1-2 mm in 
diameter). 
 Most of the isolates in this study except isolate Nyala2 didn’t grow on 
solid media upon subculture from broth or solid media, although these 
isolates grew continuously on broth media with the same constituent. It is 
clearly known that solid media for the growth of Mccp should be provided 
with purified agar, noble agar or agarose (OIE, 1991). Agar-agar was used as 
a solidifying agent in mycoplasma media in the study. It may be the reason 
for the inability of that media to support the growth of the isolates, but we 
couldn’t explain the behavior of the isolates that they grew primarily on 
solid media and unable to grow on the same media upon subculture. 
 Biochemical tests were used to identify mycoplasma isolates in this 
study, although Biochemical characteristics have little in the differentiation 
of the members of the Mycoplasma mycoides cluster, our isolates gave 
reactions similar to that of Mccp (Table 4). 
 Serological identification was carried out using the growth inhibition 
test (OIE, 1991). Unfortunately only one isolate (Nyala2) was identified 
with this method (Fig. 5) due to the fact that other isolates didn’t grow on 
solid media upon subculture. It was possible to use metabolic inhibition test 
(MIT) instead of GIT, but another problem occurred when the unidentified 
isolates were lost before identification was completed. Similar problems 
were reported in the Sudan by Abdulla and lindelly (1967) who failed to 
maintain their isolates in the laboratory for further studies. Finally the 
isolates were identified using PCR-REA. All isolates were proved to belong 
to the members of the Mycoplasma mycoides cluster as the amplified DNA 
from all isolates gave one band at 548 bp (Fig.6). Amplified DNA from 
isolate Nyala 2 was subjected to restriction enzyme analysis (REA) with 
Pst1; 3 bands were obtained at 548,420 and 128 indicating that isolate 
Nyala2 was Mycoplasma capricolum subsp. Capripneumoniae (Mccp). 
 From the presented study, although other isolates designated (N3, N4, 
N5, N9, Kh6 and Ka1) weren’t fully identified as Mccp, they seemed to be 
new strains of Mccp due to many facts. Firstly, they proved to be belonged 
to members of the M.mycoides cluster by PCR. They grew slowly giving 
small-fried egg type of colonies after 10-14 days, while other caprine 
mycoplasma in the cluster grow usually more rapidly giving larger colonies 
(OIE, 1991). Secondly, isolates Kh6 and Ka1 were recovered from animals 
showing typical symptoms of CCPP, and lesions were only restricted to 
chest cavity and that is in contrast to pleuropneumonia caused by other 
caprine mycoplasma. 
Goat sera from the investigated states were screened for antibodies 
against Mccp using CFT. Positive sera were detected in the four states 
investigated indicating that the disease is present. These results, although 
indirect may strongly confirmed our findings that all isolated mycoplasma in 
this study were belonged to Mccp. 
Antibody titres were determined in goat sera (Table 9). Higher titres 
were observed in sera collected from southern Darfur states. As no vaccines 
against CCPP have been used in the Sudan, this finding indicated recent 
natural infections with Mccp in the state. 
 
Conclusion:  
- The study gave a direct proof that CCPP is spread in Southern 
Darfur, Khartoum, Kassalla and Red Sea States. 
- Mccp can easily be isolated in Brucella and Hayflick΄s media from 
affected tissue, if standard methods are used. 
- Isolated mycoplasma grow in/on media without sodium pyruvate, 
but the addition of the later ingredient may enhance the growth of 
certain isolates. 
- The study also put future foundations for the use of PCR-REA for 
the identification of Sudan Mccp isolates. However, a proper 
channel is needed to provide the test reagents quickly, with 
affordable costs and in a good state as some reagents for example 
restriction enzyme can easily be lost during in proper storage. 
 
Recommendations: 
 
1- Detailed studies are needed to investigate the distribution of the disease 
in other country states. 
2-  Although CFT is an official test recommended by the OIE, the need for 
simple quick and easy to perform test is necessary to screen animals (eg: 
latex agglutination test) easily for antibodies against Mccp.  
3- More Strains of Mccp should be isolated to help in epidemiological 
studies and control programmes of CCPP in the Sudan. 
 CHAPTER FIVE 
 
5. References 
 
Abbas, S.I.; Erno, H.; Peterslund, K.; Harbi, M.S.M.A.; Nayil, A.A.; Aalund, 
O. (1987). Detection of antibodies against mycoplasmas in sera from cases 
of contagious caprine pleuropneumonia in the Sudan and from a reference 
group of goats. In: Contagious agalactia and other mycoplasmal diseases of 
small ruminants. Johnes (ed), Report EUR 10984 EN, CEC, Luxembourg, 
91098. 
Abdulla, A.E.D.; Harbi, M.S.M.A.; ElTahir, M.S.; Salim,M.O.; Salih,M.M. 
Mukhtar,S. (1980). Caprine pleuropneumonia, isolation of the causative 
agent and reproduction of the disease. Sud. J. Vet. Sci. and Anim. Husb. 21, 
1-9 
Abdulla, A.E.D; Lindley, E.P. (1967). A study of contagious caprine 
pleuroneumonia. Bull. Epizoot. Dis. Afr.15, 313-317.  
Abu-Groun, E.A.M.; Taylor, R.R.; Varsani, H.; Wadher, B.J.; Leach, R.H.; 
Miles, R. (1994): Biochemical diversity within the Mycoplasma mycoides 
cluster. J. Microbiol. 140, 2033-2042. 
Abusugra, I.; Wolf., G.; Bölske, G.; Thiaucourt, F.; Morein, B. (1997). ISCOM 
vaccine against contagious bovine pleuropneumonia (CBPP): I. Biochemical 
and immunological characterization. J. Vet. Immunol. Immunopathol. 78, 
667-668.  
Al-Aubaidi, J.M.; Dardiris, A.H.; Fabrocont, J. (1972). Biochemical 
characterization and antigenic relationship of Mycoplasma mycoides subsp. 
Capri (Edward) Freundt. Int. J. syst. Bacteriol. 22 : 155-164. 
Anon. (1958). Annual Report of the Sudan Veterinary Service. 
Anon. (1902). Annual report of the Veterinary Services, Government of Sudan, 
1206. 
Anon. (2001). Federal Ministry of Animal Resources and fisheries Reports.  
Aytug, N.; Dikor, F.; Dermiroz. (1991). Treatment trial with tiamulin in goats 
with caprine pleuropeumonia Veterinar. Fakutesi-Dergisi-Uludag 
Universitesi, 10, 1-2-3, 131-136. 
Babiker, H.A.S. (1971) some observations on Abu Nini. A Contagious 
pleuropneumonia of goats in Sudan. Sudan J.Vet.Sci. and Anim. Husb. 12, 
73-81. 
Bölske,G. (1995). Respiratory mycoplasmoses in goats especially with regard to 
diagnosis of CCPP.PhD thesis, Swedish University of Agricultural Sciences, 
Uppsala, Sweden. 
Bölske G; Johansson, K.E; Heinonen, R; Panvuga, P.A; Twina masiko E; 
(1995). Contagious caprine pleuropneumonia in Uganda and isolation of 
Mycoplasma capricolum sub species capripneumoniae from goats and 
sheep. Vet. Record; 137, 594. 
Bölske, G.; Mattsson, J.G.; Bascunana, C.R.; Bergström, K.; Wesonga, H.; 
Johansson, K.E (1996). Diagnosis of contagious caprine   pleuropneumona 
by detection and identification of Mycoplasma capricolum subsp. 
capripneumoniae by PCR and restriction enzyme analysis. J.Clin. Microbiol. 
34, 785-791. 
Chrisitiansen,G., and H.ErnØ.(1990). RFLP in rRNA genes of  mycoplasma 
capricolum, the caprine F38 -like group and the bovine sero group 7.Zen-
tralbl. Bakteriol. suppl. 20:479-488.  
Chu, H.P.; Beveridge, W.I.R. (1949).  A notes on the origin of strain (PG3) of 
Mycoplasma mycoides var. capri. Paper read in October 1949 at the 
Veterinary Research Club,London.  
Costas, M.; Leach, R.H.; Mitchelmore, D.L. (1987). Numerical  A nalysis of 
PAGE protein patterns and the taxonomic relationships within the 
mycoplasma mycoides Cluster.J.Gen.Microbiol. 133: 3319-3329.  
Damassa, A.J.; Wakenell, P.S.;  Brook , D.L. (1992). Mycoplasmas of  Goats 
and sheep .J.Vet . Diagn.  Invest., 4,101-113.  
El Nasri, M. (1964). The effect of tylosin against experimental and natural 
infection with mycoplasma in goats. Vet. Rec., 76, 876-877.  
Erno,H. ; Peterslund, K. (1983). Growth precipitation test .In:Methods in 
Mycoplasmology, vol.1, Razin (Tully (eds.), Academic Press, London,pp. 
489-492.  
 Freundt, E.A.; Erno, H.; Lemcke, R.M. (1979). Identification of  Mycoplasmas. 
In: Methods in Microbiology, vol. 23, Bergan and Norris (eds.), Academic 
Press, London, pP. 377-434.  
Goff, C.L.; Thiaucourt, F. (1998). Acompetitive ELISA for the specific diagnosis 
of contagious bovine pleuropneumonia (CBPP). J. Vet. Microbiol. 60, 179-
191.                                             
Harbi, M.S.M.A.; ElTahir, M.S.; MacOwan, K.J.; Nayl A.A. (1981). 
Mycoplasma strain F38 and contagious caprine pleuroneumonia in Sudan. 
Vet.Rec. 108, 261.   
Harbi, M.S.M.A.; Majeed, I.A.; El Tahir, M.S. (1983). Experimental.  contact 
transmission of contagious pleuropneumonia of goats (Abu Nini) in Sudan 
Vet . Res. Comm 6, 139-143. 
Harrison, J.C.; March, J.B. (2000): Culture of Mycoplasma capricolum subsp. 
capripneumoniae in simple growth medium (modified New’s tryptose 
broth): Evidence for distinct phenotype. In: Mycoplasmas of ruminants: 
Pathogenicity, diagnostics, epidenilogy and molecular genetics. Cost Action 
826, Agriculture and biotechnology. 4, 217-220. 
Hung, A.L.; Alvarodo, A.; Lopez, T.; Perales, R.; Garcia, O.L.E. (1991).  
Detection of antibodies to mycoplasmas in South American camelids. 
Res.Vet. Sci., 51, 250-253.  
Hutcheon, D. (1881). Contagious pleuropneumonia in angora goats. Vet. J. 
13:171-180 . 
Jones, G.E. and Wood, A.R. (1988). Microbiological and serological studies on 
caprine pneumonias in Oman. Res.Vet. Sci .44, 125-131.  
Jones ,G.E. (1992). Contagious caprine pleuropneumonia in: OIE Manual 1992 
.Office International des Epizooties, Paris, PP. 376- 392.  
Kaliner, G, and MacOwan, K.J. (1976). The pathology of experimental and 
Natural contagious caprine pleuropneumonia in Kenya. Zentrablat 
Veterinary Medicine B, 23: 652-661. 
Karib, E.A. (1958). Setting up of pleuropneumonia lung lesions by artificial 
methods. Bull. Epi. Dis. Afr., 6, pp, 277-8. 
Khan, M.I.; Lam K.m., and Yamamoto, R. (1987). Mycoplasma gallisepticum 
strain variations detected by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis .Avian Dis.31: 315-320.                                                                                     
Kumar, A. and Garg, D.N. (1991). Isolation of mycoplasma F38 from milk of 
mastitic cows.Vet. Rec. 128: 429. 
Kusiluka, L.J.M; Semuguruka, W.D; Kazwala, R.R. (2000). Demonstration of 
Mycoplasma capricolum subsp. mycoides, small colony type in out breaks of 
caprine pleuropneumonia in eastern Tanzania .  Acta Veterinaria  
Scandinavia , 41: 331-319 . 
Konsam,G.S.; Verma, B.b.; Banerjee, N.C. (1989). Efficiency of rolitetracycline 
(Reverin) in the treatment of natural cases of contagious caprine 
pleuropneumonia. Indian Veterinary Journal.  66: 770-773. 
Lefevre, P.C; Jones, G.E; OJO, M.O; (1987). Pulmonary mycoplasmosis of 
small ruminants, Revue Scientifique et Technique, Office international des 
epizooties, 6: 713-757,759- 799. 
Leach, R.H.; Erno, H.; MacOwan , K.J.(1993): Proposal for designation of F38-
type caprine mycoplasma as M. capricolum subsp. capripneumoniae subsp 
Nov.and consequent obligatory relegation of strains currently classified as 
M.capricolum (Tully,Barile, Edward,Theodore and Erno 1974) to an 
additional new subspecies, M. capricolum subsp. capricolum 
subsp.nov.Int.J.Syst.Bacteriol.43,603-605. 
Lindely, E.P. (1967) Caprine pleuropneumonia N.E.A.H.I. (Sudan) Regional 
Training Centre of  mycoplasmata. Bull.Epiz.Dis.Afr., 15, 313-317 
Litamoi, J.K.; Wanyangu, S.W. and Simam, P.K.(1990). Isolation of  
mycoplasma biotype F38 from sheep in Kenya . J.Trop. Anim. Hlth. Prod. 
22, 260-262. 
Longly, E.O. (1951). Contagious  caprine pleuropneumonia:  A study of the 
disease in Nigeria. Colonial Res. Pub/.No7.27 London H.M. Stationary  
Office. 
MacOwan, K.J. (1976). Studies on contagious caprine pleuropneumonia. PhD 
thesis, University of Edinburgh, UK. 
MacOwan, K.J.; Minette, J.E. (1976). ). A mycoplasma from chronic caprine 
pleuropneumonia in Kenya.  Trop. Anim. Hlth prod. 8, 28 -36. 
MacOwan, K.J.;  Minette, J .E. (1977) .The role of mycoplasma Strain F38 in 
contagious caprine pleuropneumonia (CCPP) in Kenya. Vet. Rec., 101, 380-381. 
McMartin, D.A; MacOwan, K.J; Swift, L.L. (1980). Acentury of classical 
contagious pleuropneumonia: from original description to aetiology. 
Brit.Vet. J., 136: 507-515. 
Mullis, K.B.; Falloona, F.A. (1987) specific synthesis of DNA in vitro via 
polymerase-catalized chain reaction methods enzymol.155. Academic press, 
London, PP. 335-350.  
Muthomi, E.K; Rurangirwa, F.R. (1983). Passive haemagglutination and 
complement fixation as diagnostic tests for contagious caprine 
pleuropneumonia caused by F38 strain of mycoplasma. Res. in Vet. Sci, 35: 
1-4.  
Newton, C.R.; Graham, A. (1997). Polymerase chain reaction (PCR) for 
detection of Leptospira (Ph.D Thesis, Univ. of  Vet. Med. Vienna, Austria). 
2nd ed., Bios Sci. publ. Oxford, UK, P.192.  
Nicholas, R.A.J. (2002). Improvements in the diagnosis and control of diseases of 
small ruminants caused by mycoplasma. J. Small Rum Res; 45: 145-149.  
OIE (1991). Contagious caprine pleuropneumonia Mannual of recommended 
diagnostic techniques and requirements for biological products. Vol III, 
B/027, 1-17. 
OIE (2000) Contagious caprine pleuropneumonia In : Mannual of Standards for 
Diagnostic Tests and Vaccines. Office International des Epizooties, 503-420. 
Ojo, M.O. (1976) .Caprine pneumonia IV: Pathogenicity of Mycoplasma mycoides 
sub species capri and caprine strains of Mycoplasma mycoides Sub species 
mycoides from goats. J. Journal of Com. Path Vol.,186: 519. 
Onovarian, O. (1974). Comparative efficacy of some antibiotics used to treat 
experimentally induced mycoplasma infection Vet. Rec. 94, 18: 418-420. 
Paling, R.W.; MacOwan, K.J.; Karstad, L. (1978). The prevalence Of antibody 
to contagious caprine pleuropneumonia (mycoplasma strain F38) in some 
wild herbivores and camels in Kenya . J. wild. I. Dis., 14, 305 -308.  
Perreau, P.; Bread, A.; Goff, C.L.E. (1984). Experimental infection of goats with 
Type F .38 mycoplasma strains (CCPP) Ann. Microbiol.135, 119 -124.  
Petterson, B.; Bölske, G.; Ronaghi, M. (1998). Molecular evolution based on 
Mycoplasma capricolum subsp. capripneumoniae strains from eastern 
Africa assessed by 16S rDNA genes. J. Bacteriol., 180: 2350-2358. 
Ros Bascunana, C.; Mattsson, J.G.; Bolske, G.; Johansson, K.E. (1994). 
Characterization of the 165 rRNA from Mycoplasma sp. strain F38 and 
development of an identification system based on PCR. J. Bacteriol. 176, 
2577-2586. 
Rurangirwa, F.R.; Masiga, W.N.; Muthomi,E. (1981): Immunity to contagious 
caprine pleuropneumonia caused by F38 strain of mycoplasma.Vet. Rec.109, 
310. 
Rurangirwa, F.R.; Masiga W.N.;  Muriu, d. N.; Muthomi E.; Mulira,G.; 
Kagumba,M.;Nandokha, E. (1981):  Treatment of contagious caprine 
pleuropneumonia. J. Trop. Anim. Hlth . prod . 13, 177-182. 
Rurangirwa, F.R.; McGuire,T.C.; Magnuson,N.S.; Kibor,A.; Chema, S. 
(1987). Composition of polysaccharide from mycoplasma (F-38) recognized 
by antibodies from goats with contagious pleuropneumonia . Res Vet. Sci., 
42,175-178. 
Rurangirwa, F.R.; Kouyate, B.; Niang, M.; McGuire ,T.C. (1990). CCPP: 
antibodies to F38 poly Saccharide in Malian goats. Vet. Rec . 127, 353.  
Rurangirwa, F.R.; McGuire,T.C . (1991). Preliminary field test of lyophilized 
contagious caprine pleuropneumonia vaccine. Res. Vet. Sci., 50: 240-241.  
Rurangirwa, F.R.; Shompole, P.S.; Wampugu, A.N.; Kihara, S.M.; MacGuire, 
T.C. (1997). Monoclonal antibody E8 -18 identifies an intergral membrane 
surface protein unique to Mycoplasma capricolum subsp. capripneumoniae 
Clin. Diog. Lab. Immunol. 4, 615 – 619.  
Saiki, R.K.; Scharf, S.; Falloona, F.A.; Mullis, K.B.; Horn, G.T.; Erlich, H.A.; 
Arnheim, N. (1985). Enzymatic amplification of ß-globin genomic 
sequences and restriction site analysis for diagnosis of sickle cell anemia. 
Science 20, 1350-1354.  
Saiki,R.K.; Gelf, D.H.; Stoffel, S.; Scharf, S.J.; Higuchi, R.; Horn, G.T.; 
Mullis, K.B.; Erlich, H.A. (1988). Primer-directed enzymeatic 
amplification of DNA with thermo stable DNA polymerase. Science 239, 
487-491.  
Thiaucourt, F.; Breard, A.; Lefevre, P.C.; Mebratu, G.Y.; (1992). Contagious 
caprine pleuropneumonia in Ethiopia. Vet. Rec. 131, 585. 
Thiaucourt, F.; Bölske,G .; Libeau, G.; Goff, C.L.; Lefevre, P.C. (1994). The 
use of monoclonal antibodies in the diagnosis of contagious caprine 
pleuropneumonia (CCPP). Vet. Microbiol. 41, 191-203. 
Thiaucourt, F.; Bölske, G. (1996). Contagious caprine pleuropneumoniae and 
other pulmonary mycoplasmoses of sheep and goats.  Rev. Scientific Tech – 
Office International Des Epizooties; 15: 1397-1414.  
Thomas, P. (1873). Report medicalsur le Bou Frida. Puplication du Government 
general civil de I Algerie 35. A. Lournal (e.d), Alger, cited by Bölske, 1995.  
Tully, J.G. (1983). Test for digitonin sensitivity and sterol requirement. Methods 
in Mycoplasmolgy,  I.E 5, 355-362.  
Turkarslan, J.; Arisoy, F. (1990) The isolation of F 38 strains from the out breaks 
of contagious caprine pleurupneumonia (CCPP) in Turkey. Pendik  Hay V. 
Hast. Merk.  Arast.  Enst.  Derg.  21, 25-29.  
Wam Wayi, H.M.; Wafula, J.S.; Litamoi, J.K; Nandokha, E.N. (1989). 
Detection of antibody to mycoplasma F38 in goat sera by an enzyme- linked 
immunosorbent assay. Trop. Anim. Hlth and Prod, 21: 43-49. 
     Wesonga,H.O.;Litamoi,J.K.;Kagumpa,M.;Wakhusama,E.(1993): Relationship 
between clinical signs and early lesions of contagious caprine pleuropneumonia 
caused by strain F38. Small Rumin.Res.10, 45-54.   
Wesonga, H.O.; Lindberg, R.; Litomoi, J.k.;  Blaske, G. (1998). Late lesions of 
experimental contagious caprine pleuropneumonia caused by Mycoplasma 
Capricolum subsp Capripneumoniae. J. Vet. Med. Series B, 45:105-114. 
Zaki, A.Z.S.A. (2001). Investigations on Cultivation of Mycoplasma capricolum 
subsp. capripneumoniae in Goettingen Bioreactor and Production of an 
Inactivated Vaccine against Contagious Caprine Pleuropneumonia. Gött. 
Beitr. Land-Forstwirtsch. Trop. Subtrop. 146. 
 
Zakia, A. (2005): The role of Clostridium perfringens in camel calf diarrhoea in 
the Sudan with special reference to pathogensis and pathological changes. 
Ph.D Thesis, U. of K.  
 
 
 
 
 
 
 
 6. Appendix 
 
6.1 Agarose 2%: 
 2g of agarose (SIGMA) was dissolved in 100 ml TAE buffer and 
heated in microwave for 45 seconds, left to cool and poured into 
electrophoresis chamber. 
 
6.2 DNA tracking (Loading Dye): 
Bromo phenol blue   11% 
Clycerol     40µl 
DDW      50 µl 
 
6.3 Ethidium bromide: 
Stock solution (PROMEGA, MADISON) 10 mg/ml and protected from 
light. 
 
6.4 Running buffer (TAE buffer): 
40 in M Tris-HCl (PH 8.0)  40 ml 
20 in M sodium acetate   20 ml 
EDTA powder (292-25 MW)  584 ml 
Complete to one liter. 
 
6.5 Standard DNA molecular weight maker (Ladder): 
100 base pair ladder (JNVITROGEN) (10 mg/ml)  20 ml 
Blue dye        80 ml 
 
 
 
